Advanced Research Projects Agency for Health (ARPA-H), established in 2022, supports transformative high-impact research to drive biomedical and health breakthroughs — ranging from molecular to societal — to provide transformative solutions for all patients.
Modeled after DARPA, this new federal agency represents an important potential funder for the CU Anschutz research community. With a $2.5B budget, this funding agency is expected to speed the development of treatment and cures for diseases, tacking the biggest threats to human health.
For ARPA-H questions, contact Erin Calhoun.
| Program | Proposer’s Day | Abstract/Solution Summary | Full Proposal |
| Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better Outcomes in Opioid Use Disorder (ASCENT-IBO) | 09/15/2026 Register here by 09/07/2026 | 10/15/2026 | 10/15/2026 |
| Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS) | Proposers Workshop: 08/24/2026 | 09/21/2026 | 11/10/2026 |
| Systems for Phenotype Evaluation, Clinical Trajectories, Response and Agency (SPECTRA) | N/A | TA 4: 10/18/2026 TA 1 & TA 2: 12/2/2026 TA 3: 01/18/2027 | To Be Announced |
| Unifying Imaging with Quantum Entanglement (UNIQUE) | 10/15/2026 Register here by 10/13/2026 | 10/30/2026 | 12/15/2026 |
| Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) | Webinar: 10/15/2026 Proposers Day Event: 11/06/2026 | 11/30/2026 | (By Invite Only) 01/22/2027 |
| Emerging Health Innovators (EHI) | Proposers Day Event (Virtual): 10/13/2026 Register Here by 10/12/2026 | 10/30/2026 | (By Invite Only) 02/10/2027 |
*General BAA closed on 3/14/2024 and replaced with the Mission Office Innovative Solutions Openings. See details on about the awarded projects to date.